102460 — Reyon Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
KR₩253bn
Enterprise Value
KR₩460bn
Revenue
KR₩151bn

Annual balance sheet for Reyon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	59,326	45,468	97,448	36,069	24,241
Net Total Accounts Receivable
Net Total Receivables	46,774	43,714	40,850	42,048	39,978
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	130,309	117,774	164,804	109,006	99,813
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	113,834	170,971	281,156	340,568	368,342
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	273,487	317,610	477,978	484,692	499,776
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33,035	48,754	47,503	47,951	125,602
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	54,282	87,521	232,741	236,926	251,151
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	219,205	230,089	245,237	247,765	248,625
Total Liabilities & Shareholders' Equity	273,487	317,610	477,978	484,692	499,776
Total Common Shares Outstanding
Total Preferred Shares Outstanding